"This FDA approval represents a disruptive paradigm shift in treatment options for millions of people who are frustrated and ...

Lenz Therapeutics has received approval from the Food and Drug Administration for Vizz (aceclidine ophthalmic solution) 1.44% ...

Known as Vizz, the once-daily eye drops treat age-related blurry near vision — also known as presbyopia — for up to 10 hours ...

It is anticipated that Vizz, manufactured by Lenz Therapeutics, will become commercially available in the US by the end of ...

The US Food and Drug Administration has approved the first eye drop that can fix near vision, promising to help ...

The Food and Drug Administration has approved the first aceclidine-based eye drop designed to improve near vision in adults ...

Detailed price information for Lenz Therapeutics Inc (LENZ-Q) from The Globe and Mail including charting and trades.

Our data shows VIZZ (aceclidine 1.44%) received FDA approval in July 2025, positioning the once-daily, preservative-free ...

For two decades, I had to douse my eyes with artificial tears to get through the day. Then I decided to see if I could shop ...

Minghui Pharmaceutical Ltd. announced it is raising $131 million in a pre-IPO financing round Aug. 7. The funds will be used to advance its cancer and inflammatory disease pipeline, which include a PD ...